Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BCO heads into its November 4 earnings report with short sellers having added meaningfully to positions over the past month, even as the stock trades well below where analysts think it should be.
The most striking tension in the data is the gap between bearish positioning and bullish analyst conviction. Short interest has climbed 14% over the past 30 days to 12.7% of the free float, a level ORTEX classifies as high. That build has been steady, with shares short rising from roughly 4.6 million in early September to 5.3 million today. Yet the analyst consensus is a firm buy, with a mean price target of $146, implying more than 40% upside from the current $102.07 price. Four analysts carry buy ratings, and the most recent actions from Goldman Sachs and Truist Securities (both in early 2026) were target increases, not cuts. Something has to give, and the November print is the next logical test.
The lending market does not support the idea that the short trade is under pressure. Availability is generous at 474%, meaning there are roughly 4.7 shares available to borrow for every one already short. That is well above the 52-week minimum of 253%, and cost to borrow remains low at 0.49%. Short sellers face no meaningful squeeze mechanics here. The ORTEX short score has held in a narrow band between 66 and 67 for the past two weeks, consistent with a steadily bearish but not escalating posture. Options traders, meanwhile, are pointing in the opposite direction. The put/call ratio of 0.21 is below its 20-day average of 0.22 and near the lower end of the past year's range (52-week low of 0.04, high of 0.78). Calls are dominant, which aligns with the analyst bull case rather than the short sellers' apparent caution.
The Street picture beyond raw targets is mixed. The 12-month forward earnings growth factor ranks in the 87th percentile, a genuinely strong reading that underpins the bull argument. Dividend score ranks in the 95th percentile, reflecting BCO's history of consistent payouts, though the dividend history in the data runs only to mid-2022, so recent yield mechanics should be verified independently. The earnings surprise factor ranks just 34th, which means BCO has not been a consistent beat-and-raise name. That matters going into November. The valuation is not demanding: PE near 10x and EV/EBITDA around 6.5x, with the EV/EBITDA multiple actually compressing slightly over the past 30 days. The short score rank sits in the 5th percentile, meaning very few stocks in the ORTEX universe carry a more bearish short positioning signal.
Institutional ownership adds one interesting layer. FMR (Fidelity) disclosed a 15% stake as of August, up sharply from 10.7% previously, and holds 6.2 million shares. That makes FMR the largest single holder by some margin, ahead of BlackRock at 12.9%. The FMR build is notable because it represents a conviction add into a stock that has drifted lower. Turtle Creek Asset Management also added significantly, more than doubling its position as of June 30 to 916,000 shares. These are not passive index flows. On the insider side, the recent EDGAR data shows only compensation-related awards and a small tax-withholding sale from the EVP and CLO in September. Net insider buying over 90 days is zero, which is neutral rather than negative.
The earnings history offers a useful baseline for what to expect on November 4. The August 2026 print triggered a 4.3% one-day decline and a further 3.4% over the following week. The prior print, in June 2026, produced a 7.4% jump on the day and 12.7% over five days. That is a wide range of outcomes, and it means positioning into the print carries real binary risk in either direction. Wikipedia page views for BCO are running about 1.5 standard deviations above their own 90-day average, a modest uptick in retail attention that may reflect the stock's recent underperformance rather than any specific catalyst.
With 27 days to the next earnings date, the question is whether the short interest build continues or stalls. The November 4 print, set against a 40%-plus analyst target gap and a low-valuation multiple, is where the two sides of this trade collide.
See the live data behind this article on ORTEX.
Open BCO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
